UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 334

Sortiert nach

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Annals of neurology, 1999-10, Vol.46 (4), p.598-605

1999

Link zum Volltext

Verfügbarkeit prüfen

Neuropathology of Parkinsonʼs Disease

Journal of neuropathology and experimental neurology, 1996-03, Vol.55 (3), p.259-272

Forno, Lysia S

1996

Link zum Volltext

Verfügbarkeit prüfen

Hereditary form of parkinsonism-dementia

Annals of neurology, 1998-06, Vol.43 (6), p.768-781

1998

Link zum Volltext

Verfügbarkeit prüfen

Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum

Journal of neurochemistry, 2004-02, Vol.88 (3), p.668-679

2004

Link zum Volltext

Verfügbarkeit prüfen

Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease

Neurology, 1998-04, Vol.50 (4), p.1136

1998

Link zum Volltext

Verfügbarkeit prüfen

Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications

Annals of neurology, 2004-02, Vol.55 (2), p.174-179

2004

Link zum Volltext

Verfügbarkeit prüfen

Interregional survey – Abruzzo, Marche, Molise – on osteoporosis risk-factors and calculations on risks for fractures in five years with the BLACK-algorithm and in ten years with the SIOMMMS-algorithm

Bone (New York, N.Y.), 2009-06, Vol.44, p.S399-S399

2009

Link zum Volltext

Verfügbarkeit prüfen

P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain

The American journal of pathology, 1996-08, Vol.149 (2), p.585-596

1996

Link zum Volltext

Verfügbarkeit prüfen

Lewy bodies and parkinsonism in families with parkin mutations

Annals of neurology, 2001-09, Vol.50 (3), p.293-300

2001

Link zum Volltext

Verfügbarkeit prüfen

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

Brain research, 1984-02, Vol.292 (2), p.390-394

1984

Link zum Volltext

Verfügbarkeit prüfen

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

Science (American Association for the Advancement of Science), 1984-09, Vol.225 (4669), p.1480-1482

1984

Link zum Volltext

Verfügbarkeit prüfen

Long-term effects of chronic methamphetamine administration in rhesus monkeys

Brain research, 1989-05, Vol.486 (1), p.73-78

1989

Link zum Volltext

Verfügbarkeit prüfen

Autopsy-proven progressive supranuclear palsy in two siblings

Neurology, 1996-04, Vol.46 (4), p.931

1996

Link zum Volltext

Verfügbarkeit prüfen

Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease

The American journal of pathology, 1996-12, Vol.149 (6), p.1839-1846

1996

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous Axonal Regeneration in Rodent Spinal Cord After Ischemic Injury

Journal of neuropathology and experimental neurology, 2002-01, Vol.61 (1), p.64-75

2002

Link zum Volltext

Verfügbarkeit prüfen

Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys

Annals of neurology, 1986-10, Vol.20 (4), p.449-455

1986

Link zum Volltext

Verfügbarkeit prüfen

Increased Susceptibility of Cytoplasmic over Nuclear Polyglutamine Aggregates to Autophagic Degradation

Proceedings of the National Academy of Sciences - PNAS, 2005-09, Vol.102 (37), p.13135-13140

2005

Link zum Volltext

Verfügbarkeit prüfen

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

JAMA : the journal of the American Medical Association, 1988-07, Vol.260 (1), p.51

1988

Link zum Volltext

Verfügbarkeit prüfen

No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease

Neurology, 1997-05, Vol.48 (5), p.1313

1997

Link zum Volltext

Verfügbarkeit prüfen

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra

Brain research, 1987-02, Vol.403 (1), p.43-51

1987

Link zum Volltext

Verfügbarkeit prüfen

Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies

The American journal of pathology, 2002-05, Vol.160 (5), p.1655-1667

2002

Link zum Volltext

Verfügbarkeit prüfen

Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders

The American journal of pathology, 1994-05, Vol.144 (5), p.1082-1088

1994

Link zum Volltext

Verfügbarkeit prüfen

1-Methyl-4-phenylpyridinium ion (MPP +): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

Neuroscience letters, 1984-07, Vol.48 (1), p.87-92

1984

Link zum Volltext

Verfügbarkeit prüfen

Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease

Experimental neurology, 1998-12, Vol.154 (2), p.684-690

1998

Link zum Volltext

Verfügbarkeit prüfen

Astrocytes and Parkinson's disease

Progress in brain research, 1992, Vol.94, p.429

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(294)
Mit Volltextzugriff
(272)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Neuropathology of Parkinsonʼs Disease

Hereditary form of parkinsonism-dementia

Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum

Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease

Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications

Interregional survey – Abruzzo, Marche, Molise – on osteoporosis risk-factors and calculations on risks for fractures in five years with the BLACK-algorithm and in ten years with the SIOMMMS-algorithm

P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain

Lewy bodies and parkinsonism in families with parkin mutations

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

Long-term effects of chronic methamphetamine administration in rhesus monkeys

Autopsy-proven progressive supranuclear palsy in two siblings

Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease

Spontaneous Axonal Regeneration in Rodent Spinal Cord After Ischemic Injury

Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys

Increased Susceptibility of Cytoplasmic over Nuclear Polyglutamine Aggregates to Autophagic Degradation

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra

Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies

Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders

1-Methyl-4-phenylpyridinium ion (MPP +): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease

Astrocytes and Parkinson's disease

Suchergebnisse filtern